Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.1300
+0.0184 (16.47%)
May 26, 2026, 3:11 PM EST
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $13.21 million as of May 27, 2026. Its market cap has increased by 55.13% in one year.
Market Cap
13.21M
Enterprise Value
16.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 13.21M, a decrease of -88.80%. That is a compound annual growth rate of -7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 13.21M | 222.14% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 16.04M |
| ZIVO Bioscience | 16.01M |
| HOOKIPA Pharma | 15.18M |
| Zeo ScientifiX | 14.56M |
| EOM Pharmaceuticals Holdings | 13.92M |
| Inhibitor Therapeutics | 13.29M |
| Finch Therapeutics Group | 11.96M |
| LianBio | 11.91M |